Effect of Treatment Regimens for Neisseria gonorrhoeae on Simultaneous Infection with Chlamydia trachomatis
We evaluated the effect of treatment for gonorrhea on simultaneous Chlamydia trachomatis infection by randomly assigning 293 heterosexual men and 246 heterosexual women with gonorrhea to receive one of the following treatment regimens: (1) 4.8 million units of aqueous procaine penicillin plus 1 g of...
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 1984-03, Vol.310 (9), p.545-549 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 549 |
---|---|
container_issue | 9 |
container_start_page | 545 |
container_title | The New England journal of medicine |
container_volume | 310 |
creator | Stamm, Walter E Guinan, Mary E Johnson, Carolyn Starcher, Thomas Holmes, King K McCormack, William M |
description | We evaluated the effect of treatment for gonorrhea on simultaneous
Chlamydia trachomatis
infection by randomly assigning 293 heterosexual men and 246 heterosexual women with gonorrhea to receive one of the following treatment regimens: (1) 4.8 million units of aqueous procaine penicillin plus 1 g of probenecid, (2) nine tablets of trimethoprim–sulfamethoxazole daily for three days, or (3) 500 mg of tetracycline four times a day for five days. Among the men, gonococcal infection was cured in 99 per cent given penicillin plus probenecid, 96 per cent given trimethoprim–sulfamethoxazole, and 98 per cent given tetracycline. Among the women, only 90 per cent given tetracycline were cured, in contrast to 97 per cent given penicillin plus probenecid and 99 per cent given trimethoprim–sulfamethoxazole.
Chlamydial infection, present in 15 per cent of the men and 26 per cent of the women, was cured in 30 of 32 patients given trimethoprim–sulfamethoxazole and 27 of 29 given tetracycline, but in only 10 of 23 given penicillin plus probenecid. Among chlamydia-positive patients, postgonococcal urethritis in men and cervicitis in women occurred more often in patients given penicillin plus probenecid. Salpingitis developed in 6 of 20 women given penicillin plus probenecid, but in only 1 of 26 given trimethoprim–sulfamethoxazole and in none of 24 given tetracycline.
We conclude that the use of penicillin plus probenecid alone for gonorrhea in heterosexual patients carries an unacceptably high risk of postgonococcal chlamydial morbidity. Trimethoprim–sulfamethoxazole and tetracycline were highly effective against both pathogens and were well tolerated in men, but both drugs caused frequent side effects in women. The failure of tetracycline to cure gonorrhea in 10 per cent of women argues against its use alone; treatment with penicillin followed by tetracycline has been recommended for further trial. (N Engl J Med 1984; 310:545–9.)
APPROXIMATELY 15 to 20 per cent of heterosexual men with gonococcal urethritis have simultaneous urethral infection with
Chlamydia trachomatis
.
1
2
3
If these men receive penicillin, single-dose ampicillin, or spectinomycin for treatment of gonorrhea, their chlamydial infection persists and causes postgonococcal urethritis or asymptomatic urethral infection.
4
5
6
In women with
Neisseria gonorrhoeae
, coinfection of the cervix with
C. trachomatis
occurs even more often (25 to 60 per cent of women with gonorrhea also have chlamydial infection
7
8
9 |
doi_str_mv | 10.1056/NEJM198403013100901 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1876078027</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4320146551</sourcerecordid><originalsourceid>FETCH-LOGICAL-c430t-387d82fe0d5fd90bc1a890633fc9daaf710644f2c5360d313b0316caf79ad4183</originalsourceid><addsrcrecordid>eNp9UE1rGzEQFaUlddL-ghAQtLew6cij1UrHYtwmIU2gTc-LrJViudYqlbSU_PvI2ORUMpcZ5n3BI-SUwQWDVny5XV7_YEpyQGDIABSwN2TGWsSGcxBvyQxgLhveKXxPjnPeQB3G1RE5EihQYTsjf5bOWVNodPQ-WV2CHQv9aR98PTJ1MdFb63O2yWv6EMeY0jpabWkc6S8fpm3Ro41TplfjzsbX9z9f1nSx3urwNFRRSdqsY9DF5w_kndPbbD8e9gn5_W15v7hsbu6-Xy2-3jSGI5QGZTfIubMwtG5QsDJMSwUC0Rk1aO06BoJzNzctChiQ4QqQCVMBpQfOJJ6QT3vfxxT_TjaXfhOnNNbInslOQCdh3lUW7lkmxZyTdf1j8kGnp55Bv-u3_0-_VXV28J5WwQ4vmkOhFf98wHU2euuSHo3PLzRVXSTbhZ_vaSHkfrSb8GroMzJejyo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1876078027</pqid></control><display><type>article</type><title>Effect of Treatment Regimens for Neisseria gonorrhoeae on Simultaneous Infection with Chlamydia trachomatis</title><source>MEDLINE</source><source>ProQuest Central UK/Ireland</source><creator>Stamm, Walter E ; Guinan, Mary E ; Johnson, Carolyn ; Starcher, Thomas ; Holmes, King K ; McCormack, William M</creator><creatorcontrib>Stamm, Walter E ; Guinan, Mary E ; Johnson, Carolyn ; Starcher, Thomas ; Holmes, King K ; McCormack, William M</creatorcontrib><description>We evaluated the effect of treatment for gonorrhea on simultaneous
Chlamydia trachomatis
infection by randomly assigning 293 heterosexual men and 246 heterosexual women with gonorrhea to receive one of the following treatment regimens: (1) 4.8 million units of aqueous procaine penicillin plus 1 g of probenecid, (2) nine tablets of trimethoprim–sulfamethoxazole daily for three days, or (3) 500 mg of tetracycline four times a day for five days. Among the men, gonococcal infection was cured in 99 per cent given penicillin plus probenecid, 96 per cent given trimethoprim–sulfamethoxazole, and 98 per cent given tetracycline. Among the women, only 90 per cent given tetracycline were cured, in contrast to 97 per cent given penicillin plus probenecid and 99 per cent given trimethoprim–sulfamethoxazole.
Chlamydial infection, present in 15 per cent of the men and 26 per cent of the women, was cured in 30 of 32 patients given trimethoprim–sulfamethoxazole and 27 of 29 given tetracycline, but in only 10 of 23 given penicillin plus probenecid. Among chlamydia-positive patients, postgonococcal urethritis in men and cervicitis in women occurred more often in patients given penicillin plus probenecid. Salpingitis developed in 6 of 20 women given penicillin plus probenecid, but in only 1 of 26 given trimethoprim–sulfamethoxazole and in none of 24 given tetracycline.
We conclude that the use of penicillin plus probenecid alone for gonorrhea in heterosexual patients carries an unacceptably high risk of postgonococcal chlamydial morbidity. Trimethoprim–sulfamethoxazole and tetracycline were highly effective against both pathogens and were well tolerated in men, but both drugs caused frequent side effects in women. The failure of tetracycline to cure gonorrhea in 10 per cent of women argues against its use alone; treatment with penicillin followed by tetracycline has been recommended for further trial. (N Engl J Med 1984; 310:545–9.)
APPROXIMATELY 15 to 20 per cent of heterosexual men with gonococcal urethritis have simultaneous urethral infection with
Chlamydia trachomatis
.
1
2
3
If these men receive penicillin, single-dose ampicillin, or spectinomycin for treatment of gonorrhea, their chlamydial infection persists and causes postgonococcal urethritis or asymptomatic urethral infection.
4
5
6
In women with
Neisseria gonorrhoeae
, coinfection of the cervix with
C. trachomatis
occurs even more often (25 to 60 per cent of women with gonorrhea also have chlamydial infection
7
8
9
10
), but the sequelae of these infections and the preventive value of gonorrhea-treatment regimens other than penicillin have rarely been studied. Rees treated women who . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM198403013100901</identifier><identifier>PMID: 6363935</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>Boston, MA: Massachusetts Medical Society</publisher><subject><![CDATA[Adolescent ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Biological and medical sciences ; Cervicitis ; Chlamydia ; Chlamydia trachomatis ; Clinical Trials as Topic ; Condoms ; Drug Administration Schedule ; Drug Combinations - administration & dosage ; Drug Combinations - adverse effects ; Female ; Gonorrhea ; Gonorrhea - complications ; Gonorrhea - drug therapy ; Gonorrhea - microbiology ; Humans ; Infections ; Inflammatory diseases ; Lymphogranuloma Venereum - complications ; Lymphogranuloma Venereum - drug therapy ; Lymphogranuloma Venereum - microbiology ; Male ; Medical sciences ; Mens health ; Morbidity ; Neisseria gonorrhoeae ; Pelvic Inflammatory Disease - epidemiology ; Penicillin ; Penicillin G Procaine - administration & dosage ; Penicillin G Procaine - adverse effects ; Pharmacology. Drug treatments ; Probenecid - administration & dosage ; Probenecid - adverse effects ; Public health ; Random Allocation ; Salpingitis ; Sex Factors ; Sexually transmitted diseases ; Stains & staining ; STD ; Sulfamethoxazole ; Sulfamethoxazole - administration & dosage ; Sulfamethoxazole - adverse effects ; Tablets ; Tetracycline - administration & dosage ; Tetracycline - adverse effects ; Trimethoprim ; Trimethoprim - administration & dosage ; Trimethoprim - adverse effects ; Trimethoprim, Sulfamethoxazole Drug Combination ; Trimethoprim-sulfamethoxazole ; Urethritis ; Urethritis - drug therapy ; Urethritis - epidemiology ; Uterine Cervicitis - drug therapy ; Uterine Cervicitis - epidemiology ; Womens health]]></subject><ispartof>The New England journal of medicine, 1984-03, Vol.310 (9), p.545-549</ispartof><rights>1985 INIST-CNRS</rights><rights>Copyright Massachusetts Medical Society Mar 1, 1984</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c430t-387d82fe0d5fd90bc1a890633fc9daaf710644f2c5360d313b0316caf79ad4183</citedby><cites>FETCH-LOGICAL-c430t-387d82fe0d5fd90bc1a890633fc9daaf710644f2c5360d313b0316caf79ad4183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1876078027?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,64385,64389,72469</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=9009817$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6363935$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Stamm, Walter E</creatorcontrib><creatorcontrib>Guinan, Mary E</creatorcontrib><creatorcontrib>Johnson, Carolyn</creatorcontrib><creatorcontrib>Starcher, Thomas</creatorcontrib><creatorcontrib>Holmes, King K</creatorcontrib><creatorcontrib>McCormack, William M</creatorcontrib><title>Effect of Treatment Regimens for Neisseria gonorrhoeae on Simultaneous Infection with Chlamydia trachomatis</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>We evaluated the effect of treatment for gonorrhea on simultaneous
Chlamydia trachomatis
infection by randomly assigning 293 heterosexual men and 246 heterosexual women with gonorrhea to receive one of the following treatment regimens: (1) 4.8 million units of aqueous procaine penicillin plus 1 g of probenecid, (2) nine tablets of trimethoprim–sulfamethoxazole daily for three days, or (3) 500 mg of tetracycline four times a day for five days. Among the men, gonococcal infection was cured in 99 per cent given penicillin plus probenecid, 96 per cent given trimethoprim–sulfamethoxazole, and 98 per cent given tetracycline. Among the women, only 90 per cent given tetracycline were cured, in contrast to 97 per cent given penicillin plus probenecid and 99 per cent given trimethoprim–sulfamethoxazole.
Chlamydial infection, present in 15 per cent of the men and 26 per cent of the women, was cured in 30 of 32 patients given trimethoprim–sulfamethoxazole and 27 of 29 given tetracycline, but in only 10 of 23 given penicillin plus probenecid. Among chlamydia-positive patients, postgonococcal urethritis in men and cervicitis in women occurred more often in patients given penicillin plus probenecid. Salpingitis developed in 6 of 20 women given penicillin plus probenecid, but in only 1 of 26 given trimethoprim–sulfamethoxazole and in none of 24 given tetracycline.
We conclude that the use of penicillin plus probenecid alone for gonorrhea in heterosexual patients carries an unacceptably high risk of postgonococcal chlamydial morbidity. Trimethoprim–sulfamethoxazole and tetracycline were highly effective against both pathogens and were well tolerated in men, but both drugs caused frequent side effects in women. The failure of tetracycline to cure gonorrhea in 10 per cent of women argues against its use alone; treatment with penicillin followed by tetracycline has been recommended for further trial. (N Engl J Med 1984; 310:545–9.)
APPROXIMATELY 15 to 20 per cent of heterosexual men with gonococcal urethritis have simultaneous urethral infection with
Chlamydia trachomatis
.
1
2
3
If these men receive penicillin, single-dose ampicillin, or spectinomycin for treatment of gonorrhea, their chlamydial infection persists and causes postgonococcal urethritis or asymptomatic urethral infection.
4
5
6
In women with
Neisseria gonorrhoeae
, coinfection of the cervix with
C. trachomatis
occurs even more often (25 to 60 per cent of women with gonorrhea also have chlamydial infection
7
8
9
10
), but the sequelae of these infections and the preventive value of gonorrhea-treatment regimens other than penicillin have rarely been studied. Rees treated women who . . .</description><subject>Adolescent</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Biological and medical sciences</subject><subject>Cervicitis</subject><subject>Chlamydia</subject><subject>Chlamydia trachomatis</subject><subject>Clinical Trials as Topic</subject><subject>Condoms</subject><subject>Drug Administration Schedule</subject><subject>Drug Combinations - administration & dosage</subject><subject>Drug Combinations - adverse effects</subject><subject>Female</subject><subject>Gonorrhea</subject><subject>Gonorrhea - complications</subject><subject>Gonorrhea - drug therapy</subject><subject>Gonorrhea - microbiology</subject><subject>Humans</subject><subject>Infections</subject><subject>Inflammatory diseases</subject><subject>Lymphogranuloma Venereum - complications</subject><subject>Lymphogranuloma Venereum - drug therapy</subject><subject>Lymphogranuloma Venereum - microbiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mens health</subject><subject>Morbidity</subject><subject>Neisseria gonorrhoeae</subject><subject>Pelvic Inflammatory Disease - epidemiology</subject><subject>Penicillin</subject><subject>Penicillin G Procaine - administration & dosage</subject><subject>Penicillin G Procaine - adverse effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Probenecid - administration & dosage</subject><subject>Probenecid - adverse effects</subject><subject>Public health</subject><subject>Random Allocation</subject><subject>Salpingitis</subject><subject>Sex Factors</subject><subject>Sexually transmitted diseases</subject><subject>Stains & staining</subject><subject>STD</subject><subject>Sulfamethoxazole</subject><subject>Sulfamethoxazole - administration & dosage</subject><subject>Sulfamethoxazole - adverse effects</subject><subject>Tablets</subject><subject>Tetracycline - administration & dosage</subject><subject>Tetracycline - adverse effects</subject><subject>Trimethoprim</subject><subject>Trimethoprim - administration & dosage</subject><subject>Trimethoprim - adverse effects</subject><subject>Trimethoprim, Sulfamethoxazole Drug Combination</subject><subject>Trimethoprim-sulfamethoxazole</subject><subject>Urethritis</subject><subject>Urethritis - drug therapy</subject><subject>Urethritis - epidemiology</subject><subject>Uterine Cervicitis - drug therapy</subject><subject>Uterine Cervicitis - epidemiology</subject><subject>Womens health</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9UE1rGzEQFaUlddL-ghAQtLew6cij1UrHYtwmIU2gTc-LrJViudYqlbSU_PvI2ORUMpcZ5n3BI-SUwQWDVny5XV7_YEpyQGDIABSwN2TGWsSGcxBvyQxgLhveKXxPjnPeQB3G1RE5EihQYTsjf5bOWVNodPQ-WV2CHQv9aR98PTJ1MdFb63O2yWv6EMeY0jpabWkc6S8fpm3Ro41TplfjzsbX9z9f1nSx3urwNFRRSdqsY9DF5w_kndPbbD8e9gn5_W15v7hsbu6-Xy2-3jSGI5QGZTfIubMwtG5QsDJMSwUC0Rk1aO06BoJzNzctChiQ4QqQCVMBpQfOJJ6QT3vfxxT_TjaXfhOnNNbInslOQCdh3lUW7lkmxZyTdf1j8kGnp55Bv-u3_0-_VXV28J5WwQ4vmkOhFf98wHU2euuSHo3PLzRVXSTbhZ_vaSHkfrSb8GroMzJejyo</recordid><startdate>19840301</startdate><enddate>19840301</enddate><creator>Stamm, Walter E</creator><creator>Guinan, Mary E</creator><creator>Johnson, Carolyn</creator><creator>Starcher, Thomas</creator><creator>Holmes, King K</creator><creator>McCormack, William M</creator><general>Massachusetts Medical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>19840301</creationdate><title>Effect of Treatment Regimens for Neisseria gonorrhoeae on Simultaneous Infection with Chlamydia trachomatis</title><author>Stamm, Walter E ; Guinan, Mary E ; Johnson, Carolyn ; Starcher, Thomas ; Holmes, King K ; McCormack, William M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c430t-387d82fe0d5fd90bc1a890633fc9daaf710644f2c5360d313b0316caf79ad4183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>Adolescent</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Biological and medical sciences</topic><topic>Cervicitis</topic><topic>Chlamydia</topic><topic>Chlamydia trachomatis</topic><topic>Clinical Trials as Topic</topic><topic>Condoms</topic><topic>Drug Administration Schedule</topic><topic>Drug Combinations - administration & dosage</topic><topic>Drug Combinations - adverse effects</topic><topic>Female</topic><topic>Gonorrhea</topic><topic>Gonorrhea - complications</topic><topic>Gonorrhea - drug therapy</topic><topic>Gonorrhea - microbiology</topic><topic>Humans</topic><topic>Infections</topic><topic>Inflammatory diseases</topic><topic>Lymphogranuloma Venereum - complications</topic><topic>Lymphogranuloma Venereum - drug therapy</topic><topic>Lymphogranuloma Venereum - microbiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mens health</topic><topic>Morbidity</topic><topic>Neisseria gonorrhoeae</topic><topic>Pelvic Inflammatory Disease - epidemiology</topic><topic>Penicillin</topic><topic>Penicillin G Procaine - administration & dosage</topic><topic>Penicillin G Procaine - adverse effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Probenecid - administration & dosage</topic><topic>Probenecid - adverse effects</topic><topic>Public health</topic><topic>Random Allocation</topic><topic>Salpingitis</topic><topic>Sex Factors</topic><topic>Sexually transmitted diseases</topic><topic>Stains & staining</topic><topic>STD</topic><topic>Sulfamethoxazole</topic><topic>Sulfamethoxazole - administration & dosage</topic><topic>Sulfamethoxazole - adverse effects</topic><topic>Tablets</topic><topic>Tetracycline - administration & dosage</topic><topic>Tetracycline - adverse effects</topic><topic>Trimethoprim</topic><topic>Trimethoprim - administration & dosage</topic><topic>Trimethoprim - adverse effects</topic><topic>Trimethoprim, Sulfamethoxazole Drug Combination</topic><topic>Trimethoprim-sulfamethoxazole</topic><topic>Urethritis</topic><topic>Urethritis - drug therapy</topic><topic>Urethritis - epidemiology</topic><topic>Uterine Cervicitis - drug therapy</topic><topic>Uterine Cervicitis - epidemiology</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stamm, Walter E</creatorcontrib><creatorcontrib>Guinan, Mary E</creatorcontrib><creatorcontrib>Johnson, Carolyn</creatorcontrib><creatorcontrib>Starcher, Thomas</creatorcontrib><creatorcontrib>Holmes, King K</creatorcontrib><creatorcontrib>McCormack, William M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stamm, Walter E</au><au>Guinan, Mary E</au><au>Johnson, Carolyn</au><au>Starcher, Thomas</au><au>Holmes, King K</au><au>McCormack, William M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of Treatment Regimens for Neisseria gonorrhoeae on Simultaneous Infection with Chlamydia trachomatis</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1984-03-01</date><risdate>1984</risdate><volume>310</volume><issue>9</issue><spage>545</spage><epage>549</epage><pages>545-549</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>We evaluated the effect of treatment for gonorrhea on simultaneous
Chlamydia trachomatis
infection by randomly assigning 293 heterosexual men and 246 heterosexual women with gonorrhea to receive one of the following treatment regimens: (1) 4.8 million units of aqueous procaine penicillin plus 1 g of probenecid, (2) nine tablets of trimethoprim–sulfamethoxazole daily for three days, or (3) 500 mg of tetracycline four times a day for five days. Among the men, gonococcal infection was cured in 99 per cent given penicillin plus probenecid, 96 per cent given trimethoprim–sulfamethoxazole, and 98 per cent given tetracycline. Among the women, only 90 per cent given tetracycline were cured, in contrast to 97 per cent given penicillin plus probenecid and 99 per cent given trimethoprim–sulfamethoxazole.
Chlamydial infection, present in 15 per cent of the men and 26 per cent of the women, was cured in 30 of 32 patients given trimethoprim–sulfamethoxazole and 27 of 29 given tetracycline, but in only 10 of 23 given penicillin plus probenecid. Among chlamydia-positive patients, postgonococcal urethritis in men and cervicitis in women occurred more often in patients given penicillin plus probenecid. Salpingitis developed in 6 of 20 women given penicillin plus probenecid, but in only 1 of 26 given trimethoprim–sulfamethoxazole and in none of 24 given tetracycline.
We conclude that the use of penicillin plus probenecid alone for gonorrhea in heterosexual patients carries an unacceptably high risk of postgonococcal chlamydial morbidity. Trimethoprim–sulfamethoxazole and tetracycline were highly effective against both pathogens and were well tolerated in men, but both drugs caused frequent side effects in women. The failure of tetracycline to cure gonorrhea in 10 per cent of women argues against its use alone; treatment with penicillin followed by tetracycline has been recommended for further trial. (N Engl J Med 1984; 310:545–9.)
APPROXIMATELY 15 to 20 per cent of heterosexual men with gonococcal urethritis have simultaneous urethral infection with
Chlamydia trachomatis
.
1
2
3
If these men receive penicillin, single-dose ampicillin, or spectinomycin for treatment of gonorrhea, their chlamydial infection persists and causes postgonococcal urethritis or asymptomatic urethral infection.
4
5
6
In women with
Neisseria gonorrhoeae
, coinfection of the cervix with
C. trachomatis
occurs even more often (25 to 60 per cent of women with gonorrhea also have chlamydial infection
7
8
9
10
), but the sequelae of these infections and the preventive value of gonorrhea-treatment regimens other than penicillin have rarely been studied. Rees treated women who . . .</abstract><cop>Boston, MA</cop><pub>Massachusetts Medical Society</pub><pmid>6363935</pmid><doi>10.1056/NEJM198403013100901</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-4793 |
ispartof | The New England journal of medicine, 1984-03, Vol.310 (9), p.545-549 |
issn | 0028-4793 1533-4406 |
language | eng |
recordid | cdi_proquest_journals_1876078027 |
source | MEDLINE; ProQuest Central UK/Ireland |
subjects | Adolescent Antibacterial agents Antibiotics. Antiinfectious agents. Antiparasitic agents Biological and medical sciences Cervicitis Chlamydia Chlamydia trachomatis Clinical Trials as Topic Condoms Drug Administration Schedule Drug Combinations - administration & dosage Drug Combinations - adverse effects Female Gonorrhea Gonorrhea - complications Gonorrhea - drug therapy Gonorrhea - microbiology Humans Infections Inflammatory diseases Lymphogranuloma Venereum - complications Lymphogranuloma Venereum - drug therapy Lymphogranuloma Venereum - microbiology Male Medical sciences Mens health Morbidity Neisseria gonorrhoeae Pelvic Inflammatory Disease - epidemiology Penicillin Penicillin G Procaine - administration & dosage Penicillin G Procaine - adverse effects Pharmacology. Drug treatments Probenecid - administration & dosage Probenecid - adverse effects Public health Random Allocation Salpingitis Sex Factors Sexually transmitted diseases Stains & staining STD Sulfamethoxazole Sulfamethoxazole - administration & dosage Sulfamethoxazole - adverse effects Tablets Tetracycline - administration & dosage Tetracycline - adverse effects Trimethoprim Trimethoprim - administration & dosage Trimethoprim - adverse effects Trimethoprim, Sulfamethoxazole Drug Combination Trimethoprim-sulfamethoxazole Urethritis Urethritis - drug therapy Urethritis - epidemiology Uterine Cervicitis - drug therapy Uterine Cervicitis - epidemiology Womens health |
title | Effect of Treatment Regimens for Neisseria gonorrhoeae on Simultaneous Infection with Chlamydia trachomatis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T15%3A48%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20Treatment%20Regimens%20for%20Neisseria%20gonorrhoeae%20on%20Simultaneous%20Infection%20with%20Chlamydia%20trachomatis&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Stamm,%20Walter%20E&rft.date=1984-03-01&rft.volume=310&rft.issue=9&rft.spage=545&rft.epage=549&rft.pages=545-549&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJM198403013100901&rft_dat=%3Cproquest_cross%3E4320146551%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1876078027&rft_id=info:pmid/6363935&rfr_iscdi=true |